XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income including non-controlling interests $ 1,480,904 $ 129,376
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation, depletion and amortization 227,856 112,581
Gain on sale of assets (521,495) (228,473)
Impairment 1,073 5
Deferred income taxes 66,668 0
Net loss on derivative instruments 128,766 550,342
Net gain from investment in unconsolidated affiliate (38,977) 0
Equity-based compensation expenses 40,351 11,187
Deferred financing costs amortization and other 1,241 18,811
Working capital and other changes:    
Change in accounts receivable, net (13,007) (65,324)
Change in inventory 2,199 2,408
Change in prepaid expenses 7,708 4,509
Change in accounts payable, interest payable and accrued liabilities 57,581 118,942
Change in other assets and liabilities, net 4,766 (9,618)
Net cash provided by operating activities 1,445,634 644,746
Cash flows from investing activities:    
Capital expenditures (303,140) (143,201)
Acquisitions, net of cash acquired (148,363) (74,500)
Proceeds from divestitures, net of cash divested 155,728 373,892
Costs related to divestitures (11,368) (2,785)
Derivative settlements (487,394) (242,437)
Proceeds from sale of investment in unconsolidated affiliate 428,231 0
Distributions from investment in unconsolidated affiliate 40,607 0
Net cash used in investing activities (325,699) (89,031)
Cash flows from financing activities:    
Proceeds from revolving credit facilities 1,035,000 384,500
Principal payments on revolving credit facilities (1,020,000) (884,500)
Proceeds from issuance of senior unsecured notes 0 850,000
Cash paid to settle Whiting debt (2,154) 0
Deferred financing costs (3,938) (20,480)
Proceeds from issuance of OMP common units, net of offering costs 0 86,592
Common control transaction costs 0 (5,453)
Purchases of treasury stock (124,845) (14,560)
Tax withholding on vesting of equity-based awards (36,768) 0
Dividends paid (500,106) (102,123)
Distributions to non-controlling interests 0 (20,443)
Payments on finance lease liabilities (570) (1,107)
Proceeds from warrants exercised 17,520 241
Net cash provided by (used in) financing activities (635,861) 272,667
Increase in cash and cash equivalents 484,074 828,382
Cash and cash equivalents:    
Beginning of period 174,783 20,226
End of period 658,857 848,608
Supplemental non-cash transactions:    
Change in accrued capital expenditures 41,348 13,014
Change in asset retirement obligations 412 (389)
Non-cash consideration exchanged in Merger 2,585,211 0
Investment in unconsolidated affiliate 568,312 0
Note receivable from divestiture 0 2,900
Contingent consideration from Permian Basin Sale 0 32,860
Dividends payable $ 27,256 $ 0